$2.27
0.062.71%
In chiusura: -
$2.28
0.009700.43%
After hour: Oct 3, 7:25 PM EDT
Comments
Loading...
Stime degli utili, EPS e fatturato
C4 Therapeutics segnala gli utili su base trimestrale. Questi report sugli utili trimestrali offrono agli investitori uno sguardo ai risultati finanziari di un'azienda per un periodo di 3 mesi. I report sugli utili includono quasi sempre i risultati EPS e i ricavi.
Data degli utili
ott 30
Stima EPS
$-0.410
Stima dei ricavi trimestrali
$6.40M
Ricavi annuali
(a partire da giu 30)
(a partire da giu 30)
$34.24M
Analizza lo storico degli utili di C4 Therapeutics utilizzando ordinamenti e filtri avanzati.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
CCCC | C4 Therapeutics | -$0.35 | -$0.41 | — | — | $15.36M | $6.40M | — | — | 10/30/2025 | |
CCCC | C4 Therapeutics | -$0.26 | -$0.38 | -$0.37 | 2.63% | $12.01M | $6.53M | $6.46M | -1.03% | 08/07/2025 | |
CCCC | C4 Therapeutics | -$0.41 | -$0.42 | -$0.37 | 11.90% | $3.04M | $2.95M | $7.24M | 145.36% | 05/07/2025 | |
CCCC | C4 Therapeutics | -$0.68 | -$0.37 | -$0.49 | -32.43% | $3.26M | $3.60M | $5.18M | 43.81% | 02/27/2025 | |
CCCC | C4 Therapeutics | -$0.55 | -$0.38 | -$0.35 | 7.89% | $11.07M | $4.60M | $15.36M | 233.96% | 10/31/2024 | |
CCCC | C4 Therapeutics | -$0.73 | -$0.37 | -$0.26 | 29.73% | $2.66M | $4.78M | $12.01M | 151.17% | 08/01/2024 | |
CCCC | C4 Therapeutics | -$0.71 | -$0.35 | -$0.41 | -17.14% | $3.76M | $8.10M | $3.04M | -62.48% | 05/08/2024 | |
CCCC | C4 Therapeutics | -$0.76 | -$0.68 | -$0.68 | 0.00% | $2.85M | $3.19M | $3.26M | 2.23% | 02/22/2024 | |
CCCC | C4 Therapeutics | -$0.65 | -$0.66 | -$0.55 | 16.67% | $6.75M | $5.46M | $11.07M | 102.78% | 11/01/2023 | |
CCCC | C4 Therapeutics | -$0.56 | -$0.69 | -$0.73 | -5.80% | $13.83M | $6.44M | $2.66M | -58.63% | 08/08/2023 | |
CCCC | C4 Therapeutics | -$0.65 | -$0.75 | -$0.71 | 5.33% | $7.65M | $5.46M | $3.76M | -31.15% | 05/04/2023 | |
CCCC | C4 Therapeutics | -$0.31 | -$0.74 | -$0.76 | -2.70% | $20.09M | $7.81M | $2.85M | -63.46% | 02/23/2023 | |
CCCC | C4 Therapeutics | -$0.51 | -$0.67 | -$0.65 | 2.99% | $8.50M | $9.07M | $6.75M | -25.53% | 11/03/2022 | |
CCCC | C4 Therapeutics | -$0.51 | -$0.69 | -$0.56 | 18.84% | $9.78M | $7.64M | $13.83M | 81.07% | 08/04/2022 | |
CCCC | C4 Therapeutics | -$0.49 | -$0.58 | -$0.65 | -12.07% | $7.43M | $8.05M | $7.65M | -4.92% | 05/05/2022 | |
CCCC | C4 Therapeutics | -$3.45 | -$0.58 | -$0.31 | 46.55% | $8.26M | $7.08M | $20.09M | 183.80% | 02/24/2022 | |
CCCC | C4 Therapeutics | -$17.55 | -$0.59 | -$0.51 | 13.56% | $8.45M | $7.61M | $8.50M | 11.70% | 11/10/2021 | |
CCCC | C4 Therapeutics | — | -$0.59 | -$0.51 | 13.56% | — | $6.02M | $9.78M | 62.48% | 08/11/2021 | |
CCCC | C4 Therapeutics | — | -$0.69 | -$0.49 | 28.99% | $6.80M | — | $7.43M | — | 05/13/2021 | |
CCCC | C4 Therapeutics | — | — | -$3.45 | — | — | — | $8.26M | — | 03/11/2021 | |
CCCC | C4 Therapeutics | -$8.93 | — | -$17.55 | — | $5.36M | — | $8.45M | — | 11/12/2020 |
C4 Therapeutics (CCCC) Guadagno per azione
Importo a sorpresa sugli utili trimestrali
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q2 | 2025-08-07 | $-0.37 | $-0.38 | 2.63 % |
| Q1 | 2025-05-07 | $-0.37 | $-0.42 | 11.9 % |
| Q4 | 2025-02-27 | $-0.49 | $-0.37 | -32.4 % |
| Q3 | 2024-10-31 | $-0.35 | $-0.38 | 7.89 % |
C4 Therapeutics (CCCC) Entrate
Importo sorpresa sulle entrate trimestrali
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q2 | 2025-08-07 | $6.46M | $6.53M | -1.03 % |
| Q1 | 2025-05-07 | $7.24M | $2.95M | 145.4 % |
| Q4 | 2025-02-27 | $5.18M | $3.60M | 43.8 % |
| Q3 | 2024-10-31 | $15.36M | $4.60M | 234.0 % |
FAQ
Quando C4 Therapeutics (NASDAQ:CCCC) riporterà gli utili?
Si prevede che C4 Therapeutics (CCCC) fornisca risultati il ottobre 30, 2025. Gli ultimi risultati sono stati pubblicati il agosto 7, 2025 per il Q2.
Quali sono stati gli ultimi utili per azione (EPS) di C4 Therapeutics (NASDAQ:CCCC)?
L'EPS effettivo era $-0.37, che superato la stima di $-0.38.
Quali sono state le entrate di C4 Therapeutics (NASDAQ:CCCC)?
Le entrate effettive sono state $6.5M, che mancato la stima di $6.5M.
Sfoglia stime sugli utili, EPS e ricavi su tutte le azioni.